Euronext NV
PAR:ENX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Euronext NV
PAR:ENX
|
NL |
|
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
|
CN |
|
Be Shaping the Future SpA
F:DAF
|
IT |
|
C
|
China Daye Non-Ferrous Metals Mining Ltd
HKEX:661
|
HK |
|
Banestes SA Banco do Estado do Espirito Santo
BOVESPA:BEES4
|
BR |
|
T
|
Telemedycyna Polska SA
WSE:TMP
|
PL |
|
T
|
Tabula Rasa HealthCare Inc
F:43T
|
US |
|
Martin Midstream Partners LP
NASDAQ:MMLP
|
US |
Wall Street
Price Targets
ENX Price Targets Summary
Euronext NV
According to Wall Street analysts, the average 1-year price target for
ENX
is 152.64 EUR
with a low forecast of 122.21 EUR and a high forecast of 178.5 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ENX's stock price target?
Price Target
152.64
EUR
According to Wall Street analysts, the average 1-year price target for
ENX
is 152.64 EUR
with a low forecast of 122.21 EUR and a high forecast of 178.5 EUR.
What is Euronext NV's Revenue forecast?
Projected CAGR
7%
For the last 2 years the
compound annual growth rate for
Euronext NV's revenue is
11%.
The projected
CAGR
for the next 3 years is
7%.
What is Euronext NV's Operating Income forecast?
Projected CAGR
11%
For the last 2 years the
compound annual growth rate for
Euronext NV's operating income is
15%.
The projected
CAGR
for the next 3 years is
11%.
What is Euronext NV's Net Income forecast?
Projected CAGR
13%
For the last 2 years the
compound annual growth rate for
Euronext NV's net income is
12%.
The projected
CAGR
for the next 3 years is
13%.
